Inside Director Lee Ji-hye of Korea Arlico Pharm Acquires 30,000 Shares via Donation, Stake Rises to 1.09%


  • Inside director Lee Ji-hye increased her holdings by 30,000 shares (0.19%p) as of May 21, 2026, to a total of 167,812 shares (1.09%)
  • Acquisition was via donation (gift), highlighting no capital outlay from the director
  • Given total outstanding shares of 15,327,021, the change is minimal, limiting impact on stock price and enterprise value
  • [AI Comprehensive Analysis]This disclosure is a routine minor change in insider ownership, neither distinctly positive nor negative for investors. Since the acquisition is via donation rather than open-market purchase, it does not convey strong insider confidence and is expected to have a neutral effect on the stock price.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Korea Arlico Pharm (260660)
  • Submission: Lee Ji-hye
  • Receipt: 05-26-2026